Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small backend/content management update. There are no changes to the study data or displayed details.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page footer revision value updated from v3.6.0 to v3.6.2. This reflects a minor backend update to the page without changing content or user-facing data.SummaryDifference0.1%

- Check33 days agoChange DetectedRecruitment status is updated to no longer looking for participants, indicating the study is terminated or not enrolling. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention label was standardized to Intervention/Treatment.SummaryDifference0.6%

- Check40 days agoChange DetectedRevision label updated to v3.5.5, indicating a minor update to the study record's presentation. This is a metadata/template change rather than an alteration to the study data or content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe revision tag on the page changed from v3.5.3 to v3.5.4, indicating a minor update to the site’s underlying version. It does not modify study content or user-facing information.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s version/revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the study record content.SummaryDifference0.1%

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.